A Comparison of DOX-SL Versus Adriamycin Plus Bleomycin Plus Vincristine in the Treatment of Severe AIDS-Related Kaposi's Sarcoma
Clinical trial NCT00002318 · UNKNOWN
Trial details
- NCT number
- NCT00002318
- Sponsor
- Sequus Pharmaceuticals
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Enrollment
- 225
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.